Aberdeen Group’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-776,364
Closed -$13.4M 901
2023
Q2
$13.4M Sell
776,364
-153,489
-17% -$3.14M 0.03% 417
2023
Q1
$22.3M Sell
929,853
-93,087
-9% -$2.02M 0.06% 322
2022
Q4
$17.7M Buy
1,022,940
+201,979
+25% +$4.26M 0.05% 357
2022
Q3
$20M Buy
820,961
+49,752
+6% +$1.71M 0.06% 316
2022
Q2
$23.9M Sell
771,209
-39,873
-5% -$1.06M 0.08% 258
2022
Q1
$28.3M Buy
811,082
+169,723
+26% +$6.42M 0.07% 257
2021
Q4
$37.9M Buy
+641,359
New +$44.4M 0.08% 237

Other funds holding CYRX

Aberdeen Group's CYRX Position: Q3 2023 in Review

Aberdeen Group sold out of CryoPort (CYRX) in Q3 2023, closing a stake of 776,364 shares — an estimated $13.4M sold.

Aberdeen Group first reported a position in CYRX in Q4 2021 and held it in 7 quarters. The position peaked at $37.9M in Q4 2021. 158 funds tracked by Wall St. Rank hold CYRX as of Q3 2023.

  • Aberdeen Group reported no remaining CryoPort position as of Q3 2023 after selling out during the quarter.
  • Aberdeen Group sold 776,364 CryoPort shares in Q3 2023, an estimated $13.4M.
  • Aberdeen Group first reported a position in CryoPort in Q4 2021 and held it in 7 quarters.
  • Aberdeen Group's CryoPort position peaked at $37.9M in Q4 2021.
  • 158 funds tracked by Wall St. Rank held CryoPort as of Q3 2023.

Based on Aberdeen Group's 13F filing for Q3 2023, filed 7 Nov 2023.